MENU
+Compare
TVTX
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$17.18
Change
-$0.22 (-1.26%)
Capitalization
1.5B

TVTX Travere Therapeutics Forecast, Technical & Fundamental Analysis

a biopharmaceutical company, which develops pharmaceutical products

Industry Biotechnology
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for TVTX with price predictions
Dec 20, 2024

Momentum Indicator for TVTX turns negative, indicating new downward trend

TVTX saw its Momentum Indicator move below the 0 level on December 11, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 99 similar instances where the indicator turned negative. In of the 99 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for TVTX turned negative on December 09, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

TVTX moved below its 50-day moving average on December 12, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TVTX crossed bearishly below the 50-day moving average on December 19, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TVTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TVTX's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TVTX advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .

TVTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 218 cases where TVTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TVTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TVTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (70.423) is normal, around the industry mean (14.529). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). TVTX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (6.523) is also within normal values, averaging (255.281).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TVTX is expected to report earnings to fall 9.06% to -63 cents per share on March 03

Travere Therapeutics TVTX Stock Earnings Reports
Q4'24
Est.
$-0.64
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.14
Q1'24
Beat
by $2.43
Q4'23
Beat
by $2.12
The last earnings report on October 31 showed earnings per share of -69 cents, missing the estimate of -66 cents. With 3.70M shares outstanding, the current market capitalization sits at 1.50B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which develops pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3611 Valley Centre Drive
Phone
+1 888 969-7879
Employees
380
Web
https://www.travere.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KDHIX54.120.65
+1.22%
DWS CROCI Equity Dividend Inst
PEGCX20.320.24
+1.20%
PGIM Jennison Mid-Cap Growth C
DBORX23.420.20
+0.86%
BNY Mellon Balanced Opportunity I
SEKCX16.250.11
+0.68%
DWS Emerging Markets Equity C
MINIX38.760.21
+0.54%
MFS International Intrinsic Value I

TVTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with RLAY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
-1.26%
RLAY - TVTX
44%
Loosely correlated
-2.35%
ACLX - TVTX
40%
Loosely correlated
+0.44%
XNCR - TVTX
38%
Loosely correlated
+0.50%
PGEN - TVTX
38%
Loosely correlated
+5.07%
NKTX - TVTX
38%
Loosely correlated
+7.73%
More